View more
This product has multiple variants. The options may be chosen on the product page
From £29.99
Hepatitis C is a significant cause of mortality in hemodialysis patients. This book analyzes the “two sides of the same coin”—the benefits and adverse effects of peginterferon alpha therapy. Based on a unique national study, it raises awareness of HCV prevention.
Hepatitis C is a significant cause of mortality in hemodialysis patients. This book analyzes the “two sides of the same coin”—the benefits and adverse effects of peginterferon alpha therapy. Based on a unique national study, it raises awareness of HCV prevention.
View more
This product has multiple variants. The options may be chosen on the product page